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Gold-catalyzed intermolecular oxidation of chiral
homopropargyl sulfonamides: a reliable access to
enantioenriched pyrrolidin-3-ones†
Chao Shu, Long Li, Yong-Fei Yu, Shuang Jiang and Long-Wu Ye*
A gold-catalyzed intermolecular oxidation of chiral homopropargyl
sulfonamides has been developed, which provides a reliable access
to synthetically useful chiral pyrrolidin-3-ones with excellent ee, by
combining the chiral tert-butylsulfinimine chemistry and gold cat-
alysis. This methodology has also been used in the facile synthesis
of natural product ()-irniine. The use of readily available starting
materials, a broad substrate scope, a simple procedure and the mild
nature of this reaction render it a viable alternative for the synthesis
of enantioenriched pyrrolidin-3-ones.
The pyrrolidin-3-one moiety has received considerable interest
because of its frequent occurrence in a large number of bioactive
natural and non-natural molecules and has therefore been used as a
privileged structural subunit for the design of several pharmaceutical
agents.1 In addition, pyrrolidin-3-ones also served as valuable
building blocks for the construction of complex molecules due to
their latent reactivity and the large panel of highly selective transfor-
mations they can undergo.2 However, despite numerous preparative
methods developed during the past decade,3 there are very few
examples of enantioselective synthesis of pyrrolidin-3-ones, especially
those with high enantioselectivity, flexibility and good modularity.4
Recent rapid development in gold-catalyzed oxygen-atom transfer
reactions offers easy access to an incredible variety of functionalized
carbo- and heterocycles.5–8 In this regard, Shin and co-workers reported
an elegant protocol for the synthesis of functionalized pyrrolidin-3-
ones involving a gold-catalyzed intramolecular oxygen-transfer
Scheme 1 Formation of pyrrolidin-3-ones through gold-catalyzed oxygen-
atom transfer to alkynes.
Table 1 Optimization of reaction conditionsa




1 PPh3 4a (2-Br) 1.1 equiv. MsOH 37 o2
2 PPh3 4b (3,5-Cl2) 1.1 equiv. MsOH 28 8
3 PPh3 4c (2,6-Br2) 1.1 equiv. MsOH 32 15
4 PPh3 4d (3-Cl) 1.1 equiv. MsOH 39 12
5 PPh3 5
d 1.1 equiv. MsOH 35 o5
6 XPhos 4a (2-Br) 1.1 equiv. MsOH 50 o2
7 Cy-JohnPhos 4a (2-Br) 1.1 equiv. MsOH 34 o2
8 BrettPhos 4a (2-Br) 1.1 equiv. MsOH 43 o2
9 (4-CF3C6H4)3P 4a (2-Br) 1.1 equiv. MsOH 26 o2
10 Et3P 4a (2-Br) 1.1 equiv. MsOH 72 o2
11 IPr 4a (2-Br) 1.1 equiv. MsOH 42 o2
12 Mor-DalPhos 4a (2-Br) 1.1 equiv. MsOH 65 o2
13 Au(III)c 4a (2-Br) 1.1 equiv. MsOH 20 o2
14 Et3P 4a (2-Br) 0.5 equiv. MsOH 48 o2
15 Et3P 4a (2-Br) / 43 o2
16 Et3P 4a (2-Br) 1.8 equiv. MsOH 55 o2
17 Et3P 4a (2-Br) 1.1 equiv. CF3CO2H 69 o2
18 Et3P 4a (2-Br) 1.1 equiv. HNTf2 36 o2
a Reaction conditions: [1a] = 0.05 M; DCE: 1,2-dichloroethane. b Esti-
mated by 1H NMR using diethyl phthalate as an internal reference.
c Dichloro(2-picolinato)gold(III). d 8-methylquinoline 1-oxide.
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redox cyclization (Scheme 1).9 In our recent study toward gold-
catalyzed 5-endo-dig cyclization of terminal alkynes, we reported
gold-catalyzed tandem cycloisomerization–oxidation and tandem
cycloisomerization–dimerization from readily available chiral
homopropargyl sulfonamides, leading to the efficient formation of
enantioenriched g-lactams and pyrrolidines, respectively.10 Inspired
by these results, we envisioned that enantioenriched pyrrolidin-3-
ones might be accessed directly from chiral homopropargyl sulfon-
amides through a gold-catalyzed intermolecular oxygen-transfer
redox cyclization, providing a flexible and alternative way for the
preparation of versatile pyrrolidin-3-one derivatives (Scheme 1).
In this communication, we describe herein the realization of
such a gold-catalyzed intermolecular alkyne oxidation, affording
chiral pyrrolidin-3-ones in moderate to good yields and excellent
enantioselectivities by successful combination of the chiral tert-
butylsulfinimine chemistry with gold catalysis. The synthetic utility
of this protocol was demonstrated by the enantioselective total
synthesis of natural product ()-irniine.
Our initial investigation focused on the reaction of homo-
propargyl sulfonamide substrate 1a with pyridine N-oxide 4 in
DCE at room temperature in the presence of a gold(I) complex
(5 mol%). To our delight, the desired pyrrolidin-3-one 2a was
indeed formed under the optimal conditions established by
Zhang for propargylic alcohol substrates (Table 1, entry 1).6h
However, the yield of this reaction was only 37%, indicating
that the sulfonamide here behaved very differently from its
Table 2 Reaction scope for the formation of enantioenriched pyrrolidin-3-onesa













































a Reactions run in vials; [1] = 0.05 M; isolated yields are reported; ees are determined using HPLC on a chiral stationary phase. b Using (S)-(+)-tert-














































2524 | Chem. Commun., 2014, 50, 2522--2525 This journal is©The Royal Society of Chemistry 2014
alcohol counterpart. Varying the oxidants did not improve the
reaction (Table 1, entries 2–5). Here, it should be mentioned
that a significant amount of dimer 3a was formed through
gold-catalyzed tandem cycloisomerization–dimerization in
some cases.10a Correlated with our previously reported gold-
catalyzed tandem cycloisomerization–oxidation reaction,10b we
speculate that the differential reactivity of the starting materials
mainly depends on the nucleophilicity of the oxidants. More
nucleophilic oxidants such as pyridine N-oxides here would
attack the gold-activated alkynes directly to deliver the a-oxo
gold carbenoids, which finally led to the formation of
3-pyrrolidones. However, in the presence of less nucleophilic
oxidants such as m-CPBA, the reaction would proceed through a
gold-catalyzed cycloisomerization and subsequent oxidation,
while a tandem cycloisomerization–dimerization occurred in
the absence of the oxidant. Screening of different gold catalysts
(Table 1, entries 6–13) revealed that Et3PAuNTf2 was best
suited for this reaction (Table 1, entry 10), followed by
Mor-DalPhosAuNTf2 (Table 1, entry 12).
6a,b In addition, the
effect of acid was also investigated and it was found that the
use of other acids failed to improve the yield (Table 1, entries
14–18). Notably, no pyrrolidin-3-one was observed under acidic
conditions in the absence of the gold catalyst, and PtCl2 was not
effective in promoting this reaction.
The chiral homopropargyl sulfonamide substrates were then
prepared with excellent enantiomeric excesses according to
Ellman’s tert-butylsulfinimine chemistry.11 With these sub-
strates in hand, we then probed the generality of the current
reaction. As shown in Table 2, homopropargyl sulfonamides 1
could undergo smooth cyclization to produce the corres-
ponding pyrrolidin-3-ones 2 in moderate to good yields. Of
note, a range of functional groups were well tolerated during
the cyclization reaction, including phenyl (Table 2, entry 3),
azido (Table 2, entry 4), protected amino (Table 2, entry 5), and
hydroxy (Table 2, entry 6). Importantly, excellent enantio-
selectivities could be achieved in all cases and essentially no
epimerization was observed, constituting a good combination
of chiral tert-butylsulfinimine chemistry with gold catalysis.
In addition, the use of (S)-(+)-tert-butylsulfinamide-derived
homopropargyl sulfonamide 1a0 also furnished the corres-
ponding pyrrolidin-3-one 2a0 with the opposite enantio-
selectivity (Table 2, entry 15). Thus, this protocol allows a rapid
and practical access to both enantiomers of pyrrolidin-3-one 2
just by the choice of the starting chiral source. This chemistry
can also be extended to the preparation of parent pyrrolidin-3-
one 2o and 5,5-disubstituted pyrrolidin-3-one 2p in fairly good
yields (70% and 55% isolated yields, Table 2, entry 16). Besides
the tosyl group, it was found that the reaction could proceed
well for Bs and Ns protected substrates 1q–1r, resulting in good
yields of the desired products 2q–2r (70% and 65% isolated
yields, Table 2, entries 17 and 18) with excellent ees, providing
an easier way for its later removal.
As shown in eqn (1), attempts to expand this chemistry to
internal alkynes were not successful presumably due to the
competing gold-catalyzed hydration reaction and 1,2-C–H
insertion via an a-oxo gold carbene intermediate.6f,8k Notably,
no migration of the sulfonyl group was observed in this case, as
previously described in Shin’s Chemistry.9
(1)
The significance of this methodology is additionally demon-
strated by its application to the enantioselective total synthesis
of ()-irniine (Scheme 2).12 Chiral homopropargyl sulfonamide
substrate 1s was prepared from 10-phenyldecanal in a four-step
process according to our well-established sequence. Then, the
treatment of substrate 1s under the previously optimized reac-
tion conditions allowed the formation of pyrrolidin-3-one 2s in
63% yield with excellent enantioselectivity. The removal of the
carbonyl group, followed by replacement of the tosyl group with
the methyl group, furnished the final ()-irniine 6. Thus, the
preparation of ()-irniine was accomplished in 9 steps from
readily available 10-phenyldecanal in 12.2% overall yield.
Importantly, this protocol represents a new access to versatile
optically active N-methyl pyrrolidine derivatives,13 and nicely
complements the method we have developed very recently.10b
In summary, we have developed a gold-catalyzed intermolecular
oxidation of chiral homopropargyl sulfonamides, allowing the
convenient synthesis of optically active pyrrolidin-3-ones in combi-
nation with chiral tert-butylsulfinimine chemistry. With this newly
established methodology, the enantioselective total synthesis of
natural product ()-irniine could be easily achieved in a highly
efficient and concise manner. Further investigations into the
synthetic applications of the current protocol are in progress in
our laboratory.
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